Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Clin Ther. 2014 Jul 30;36(9):1244–1254. doi: 10.1016/j.clinthera.2014.06.030

Table 3.

Pharmacist Actions for Anti-Hypertensive Medication Therapy Management

Initial Visit
(n=73)
6 Month Visit
(n=60)
9 Month Visit
(n=51)
Patients with a drug therapy problem identified n (%) 33 (45.2%) 12 (20.0%) 4 (7.8%)

Type of drug therapy problem n (%) of total w/problems
Need for additional therapy 14 (42.4%) 7 (58.3%) 1 (25.0%)
Drug dose too low 11 (33.3%) 3 (25.0%) 1 (25.0%)
Non-adherence to therapy 5 (15.2%) 1 (8.3%) 1 (25.0%)
Adverse drug reaction 2 (6.1%) 2 (16.7%) 0 (0.0%)

Patients with a medication change at visit n (%) 25 (34.3%) 7 (11.7%) 2 (3.9%)

Patients with type of change made n (%) of total w/change
Added Medication 8 (32.0%) 2 (28.6%) 0 (0.0%)
Increased Dose 15 (60.0%) 3 (42.9%) 2 (100.0%)
Decreased Dose 2 (8.0%) 1 (14.3%) 0 (0.0%)
Changed Medication 3 (12.0%) 1 (14.3%) 0 (0.0%)

Note: Patients may have had multiple drug therapy problems or medication changes.